UC Irvine   

Questions discussed in this category



Would you consider this de novo DLBCL (unable to assess for clonality)? How would you handle prior anthracycline exposure? 

240-300 mg/m2 prior exposure. How would your management change in young fit/older individuals with comorbidities? Would you obtain interval TTE during...


Papers discussed in this category


Eur J Haematol, 2023 Mar 27

Ann Oncol, 2009 Jul 01

Blood, 2010 Jul 21

N Engl J Med, 2022 Jun 03

J Hematol Oncol, 2021 Oct 30